About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 576479, 12 pages
http://dx.doi.org/10.1155/2013/576479
Review Article

Potential Effects of Medicinal Plants and Secondary Metabolites on Acute Lung Injury

1Departamento de Clínica Médica, Laboratório de ImunoFarmacologia Experimental, Instituto de Ciências da Saúde, Universidade Federal do Triângulo Mineiro, Rua Manoel Carlos 162, 38025-380 Uberaba, MG, Brazil
2Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro (UFTM), Uberaba, MG, Brazil

Received 3 May 2013; Revised 16 August 2013; Accepted 23 August 2013

Academic Editor: Edineia Lemos de Andrade

Copyright © 2013 Daniely Cornélio Favarin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. G. Ashbaugh, D. B. Bigelow, T. L. Petty, and B. E. Levine, “Acute respiratory distress in adults,” The Lancet, vol. 2, no. 7511, pp. 319–323, 1967. View at Scopus
  2. N. D. Eves, Y. Song, A. A. Piper, and T. M. Maher, “Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology,” Respirology, vol. 18, no. 3, pp. 555–573, 2013. View at Publisher · View at Google Scholar
  3. M. Donahoe, “Acute respiratory distress syndrome: a clinical review,” Pulmonary Circulation, vol. 1, pp. 192–211, 2011.
  4. R. Randhawa and G. Bellingan, “Acute lung injury,” Anaesthesia and Intensive Care Medicine, vol. 8, no. 11, pp. 477–480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. Zilberberg and S. K. Epstein, “Acute lung injury in the medical ICU—comorbid conditions, age, etiology, and hospital outcome,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 4, pp. 1159–1164, 1998. View at Scopus
  6. V. M. Ranieri, G. D. Rubenfeld, B. T. Thompson et al., “Acute respiratory distress syndrome: the Berlin definition,” Journal of the American Medical Association, vol. 20, pp. 2526–2533, 2012.
  7. G. R. Bernard, A. Artigas, K. L. Brigham et al., “The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, pp. 818–824, 1994. View at Scopus
  8. T. Zhu, W. Zhang, and D.-X. Wang, “Insulin up-regulates epithelial sodium channel in LPS-induced acute lung injury model in rats by SGK1 activation,” Injury, vol. 8, pp. 1277–1250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Hofstra, A. D. Cornet, P. J. Declerck et al., “Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury,” PLoS ONE, vol. 8, pp. 552–562, 2013.
  10. V. von Dossow-Hanfstingl, “Advances in therapy for acute lung injury,” Anesthesiology Clinics, vol. 30, pp. 629–639, 2012.
  11. X. Fang, C. Bai, and X. Wang, “Bioinformatics insights into acute lung injury/acute respiratory distress syndrome,” Clinical and Translational Medicine, vol. 1, article 9, 2012. View at Publisher · View at Google Scholar
  12. M. A. Matthay, L. B. Ware, and G. A. Zimmerman, “The acute respiratory distress syndrome,” The Journal of Clinical Investigation, vol. 122, pp. 2731–2740, 2012. View at Publisher · View at Google Scholar
  13. A. J. Walkey, R. Summer, V. Ho, and P. Alkana, “Acute respiratory distress syndrome: epidemiology and management approaches,” Journal of Clinical Epidemiology, vol. 4, pp. 159–169, 2012.
  14. A. MacKay and M. Al-Haddad, “Acute lung injury,” Anaesthesia and Intensive Care Medicine, vol. 11, no. 11, pp. 487–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. R. Johnson and M. A. Matthay, “Acute lung injury: epidemiology, pathogenesis, and treatment,” Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 23, no. 4, pp. 243–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Wilson and M. Takata, “Inflammatory mechanisms of ventilator-induced lung injury: a time to stop and think?” Anaesthesia, vol. 68, pp. 175–178, 2013.
  17. S. Zhang, S. D. Danchuk, K. M. Imhof et al., “Comparison of the therapeutic effects of human and mouse adipose- derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury,” Stem Cell Research & Therapy, vol. 4, pp. 13–20, 2013.
  18. X. Y. Chen, S. M. Wang, N. Li et al., “Creation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in rats,” PLoS ONE, vol. 8, pp. 58–75, 2013.
  19. Y. L. Xu, Y. L. Liu, Q. Wang, G. Li, X. D. Lü, and B. Kong, “Intravenous transplantation of mesenchymal stem cells attenuates oleic acid induced acute lung injury in rats,” Chinese Medical Journal, vol. 8, pp. 125–136, 2012.
  20. A. T. Reddy, S. P. Lakshmi, and R. C. Reddy, “The nitrated fatty acid 10-nitro-oleate diminishes severity of LPS-induced acute lung injury in mice,” PPAR Research, vol. 2012, Article ID 617063, 12 pages, 2012. View at Publisher · View at Google Scholar
  21. J. Grommes, S. Vijayan, M. Drechsler et al., “Simvastatin reduces endotoxin-induced acute lung,” PLoS ONE, vol. 7, Article ID e38917, 2012.
  22. H. Inoue, Y. Nakagawa, M. Ikemura, E. Usugi, and M. Nata, “Molecular-biological analysis of acute lung injury (ALI) induced by heat exposure and/or intravenous administration of oleic acid,” Legal Medicine, vol. 6, pp. 304–312, 2012.
  23. G. Matute-Bello, C. W. Frevert, and T. R. Martin, “Animal models of acute lung injury,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 295, no. 3, pp. L379–L399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Ehrentraut, E. T. Clambey, E. N. McNamee et al., “CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury,” The FASEB Journal, vol. 27, no. 6, pp. 2207–2219, 2013.
  25. M. Bhargava and C. H. Wendt, “Biomarkers in acute lung injury,” Translational Research, vol. 159, no. 4, pp. 205–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. El Kebir, P. Gjorstrup, and J. G. Filep, “Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 37, pp. 14983–14988, 2012. View at Publisher · View at Google Scholar
  27. R. P. Baughman, K. L. Gunther, M. C. Rashkin, D. A. Keeton, and E. N. Pattishall, “Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 1, pp. 76–81, 1996. View at Scopus
  28. S. Matsuo, W. L. Yang, M. Aziz, A. Jacob, and P. Wang, “Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion,” The Journal of Critical Care, vol. 17, pp. 5–19, 2013.
  29. J. Grommes and O. Soehnlein, “Contribution of neutrophils to acute lung injury,” Molecular Medicine, vol. 17, no. 3-4, pp. 293–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Freudenberg, S. Tchaptchet, S. Keck et al., “Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity,” Immunobiology, vol. 213, no. 3-4, pp. 193–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Liaudet, P. Á. L. Pacher, J. G. Mabley et al., “Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 3, pp. 372–377, 2002. View at Scopus
  32. H.-X. Li, J.-C. Zhang, Y.-L. Zhao, and H.-J. Hao, “Effects of interleukin-10 on expression of inflammatory mediators and anti-inflammatory mediators during acute lung injury in rats,” Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, vol. 17, no. 6, pp. 338–341, 2005. View at Scopus
  33. A. B. Lentsch, B. J. Czermak, J. A. Jordan, and P. A. Ward, “Regulation of acute lung inflammatory injury by endogenous IL-13,” Journal of Immunology, vol. 162, no. 2, pp. 1071–1076, 1999. View at Scopus
  34. J. Corne, G. Chupp, C. G. Lee et al., “IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury,” The Journal of Clinical Investigation, vol. 106, no. 6, pp. 783–791, 2000. View at Scopus
  35. A. Ortega-Gómez, M. Perretti, and O. Soehnlein, “Resolution of inflammation: an integrated view,” EMBO Molecular Medicine, vol. 5, no. 5, pp. 661–674, 2013. View at Publisher · View at Google Scholar
  36. D. El Kebir and J. G. Filep, “Modulation of neutrophil apoptosis and the resolution of inflammation through β2 integrins,” Frontiers in Immunology, vol. 4, article 60, 2013. View at Publisher · View at Google Scholar
  37. S. Krishnamoorthy, A. Recchiuti, N. Chiang et al., “Resolvin D1 binds human phagocytes with evidence for proresolving receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1660–1665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. C. N. Serhan, S. D. Brain, C. D. Buckley et al., “Resolution of inflammation: state of the art, definitions and terms,” The FASEB Journal, vol. 21, no. 2, pp. 325–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. B. D. Levy, G. T. de Sanctis, P. R. Devchand et al., “Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4,” Nature Medicine, vol. 8, no. 9, pp. 1018–1023, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. C. N. Serhan, S. Hong, K. Gronert et al., “Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals,” Journal of Experimental Medicine, vol. 196, no. 8, pp. 1025–1037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Cepkova and M. A. Matthay, “Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome,” Journal of Intensive Care Medicine, vol. 21, no. 3, pp. 119–143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. C. M. Yamashita and J. F. Lewis, “Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome,” Expert Opinion on Emerging Drugs, vol. 17, no. 1, pp. 1–4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Fukunaga, P. Kohli, C. Bonnans, L. E. Fredenburgh, and B. D. Levy, “Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury,” Journal of Immunology, vol. 174, no. 8, pp. 5033–5039, 2005. View at Scopus
  44. G. Matute-Bello, C. W. Frevert, O. Kajikawa et al., “Septic shock and acute lung injury in rabbits with peritonitis: failure of the neutrophil response to localized infection,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 1, pp. 234–243, 2001. View at Scopus
  45. W. D. Hardie, D. R. Prows, G. D. Leikauf, and T. R. Korfhagen, “Attenuation of acute lung injury in transgenic mice expressing human transforming growth factor-α,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 277, no. 5, pp. L1045–L1050, 1999. View at Scopus
  46. Y. Song, N. Fukuda, C. Bai, T. Ma, M. A. Matthay, and A. S. Verkman, “Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice,” Journal of Physiology, vol. 525, no. 3, pp. 771–779, 2000. View at Scopus
  47. L. Hsu, T. McDermott, L. Brown, and S. M. Aguayo, “Transgenic HbS mouse neutrophils in increased susceptibility to acute lung injury: implications for sickle acute chest syndrome,” Chest, vol. 116, no. 1, supplement, p. 92S, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Hsu, T. McDermott, Y. Gu, L. S. Brown, and S. M. Aguayo, “Transgenic mice neutrophils in increased susceptibility to acute lung injury- implications for sickle acute chest syndrome,” Pediatric Research, vol. 43, p. 133, 1998.
  49. C. C. dos Santos, D. Okutani, P. Hu et al., “Differential gene profiling in acute lung injury identifies injury-specific gene expression,” Critical Care Medicine, vol. 36, no. 3, pp. 855–865, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. C. Wesselkamper, D. R. Prows, P. Biswas, K. Willeke, E. Bingham, and G. D. Leikauf, “Genetic susceptibility to irritant-induced acute lung injury in mice,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 279, no. 3, pp. L575–L582, 2000. View at Scopus
  51. A. Y. Meliton, N. M. Muñoz, L. N. Meliton, A. A. Birukova, A. R. Leff, and K. G. Birukov, “Mechanical induction of group V phospholipase A2 causes lung inflammation and acute lung injury,” American Journal of Physiology—Lung Cellular and Molecular, vol. 304, no. 10, pp. L689–L700, 2013. View at Publisher · View at Google Scholar
  52. X. Huang and Y. Y. Zhao, “Transgenic expression of FoxM1 promotes endothelial repair following lung injury induced by polymicrobial sepsis in mice,” PLoS ONE, vol. 7, article 11, 2012.
  53. J. E. Levitt and M. A. Matthay, “Clinical review: early treatment of acute lung injury—paradigm shift toward prevention and treatment prior to respiratory failure,” Critical Care, vol. 16, p. 223, 2012.
  54. S. Tasaka, N. Hasegawa, and A. Ishizaka, “Pharmacology of acute lung injury,” Pulmonary Pharmacology and Therapeutics, vol. 15, no. 2, pp. 83–95, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. J. B. Calixto, A. Beirith, J. Ferreira, A. R. Santos, V. C. Filho, and R. A. Yunes, “Naturally occurring antinociceptive substances from plants,” Phytotherapy Research, vol. 14, pp. 401–418, 2000.
  56. J. B. Calixto, M. M. Campos, M. F. Otuki, and A. R. S. Santos, “Anti-inflammatory compounds of plant origin—part II: modulation of pro-inflammatory cytokines, chemokines and adhesion molecules,” Planta Medica, vol. 70, no. 2, pp. 93–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Verpoorte, “Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development,” Drug Discovery Today, vol. 3, no. 5, pp. 232–238, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Seelinger, I. Merfort, and C. M. Schempp, “Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin,” Planta Medica, vol. 74, no. 14, pp. 1667–1677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Zhu, D. X. Wang, W. Zhang et al., “Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB,” PLoS ONE, vol. 8, 2013.
  60. D. C. Favarin, M. M. Teixeira, E. L. Andrade et al., “Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice,” Mediators of Inflammation, vol. 2013, Article ID 164202, 13 pages, 2013. View at Publisher · View at Google Scholar
  61. A. P. Rogerio, C. Fontanari, M. C. C. Melo et al., “Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid,” Journal of Pharmacy and Pharmacology, vol. 58, no. 9, pp. 1265–1273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. A. P. Rogerio, A. Sá-Nunes, and L. H. Faccioli, “The activity of medicinal plants and secondary metabolites on eosinophilic inflammation,” Pharmacological Research, vol. 62, no. 4, pp. 298–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. H.-B. Bae, M. Li, J.-P. Kim et al., “The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model,” Inflammation, vol. 33, no. 2, pp. 82–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. K. J. Xu, S. F. Zhang, and Q. X. Li, “Preventive and treatment effect of composite Rhodiolae on acute lung injury in patients with severe pulmonary hypertension during extracorporeal circulation,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 23, pp. 648–650, 2003.
  65. C. Zhang, C. Ren, H. Chen et al., “The analog of Ginkgo biloba extract 761 is a protective factor of cognitive impairment induced by chronic fluorosis,” Biological Trace Element Research, vol. 153, no. 1–3, pp. 229–236, 2013. View at Publisher · View at Google Scholar
  66. F. Qiu, J. B. Friesen, J. B. McAlpine, and G. F. Pauli, “Design of countercurrent separation of Ginkgo biloba terpene lactones by nuclear magnetic resonance,” Journal of Chromatography A, vol. 1242, pp. 26–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Jaracz, K. Strømgaard, and K. Nakanishi, “Ginkgolides: selective acetylations, translactonization, and biological evaluation,” Journal of Organic Chemistry, vol. 67, no. 13, pp. 4623–4626, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. A. S. El-Khatib, A. M. Moustafa, A.-A. H. Abdel-Aziz, O. A. Al-Shabanah, and H. A. El-Kashef, “Ginkgo biloba extract (EGb 761) modulates bleomycin-induced acute lung injury in rats,” Tumori, vol. 87, no. 6, pp. 417–422, 2001. View at Scopus
  69. R. Sun, H. Zhang, Q. Si, and S. Wang, “Protective effect of Ginkgo biloba extract on acute lung injury induced by lipopolysaccharide in D-galactose aging rats,” Zhonghua Jie He He Hu Xi Za Zhi, vol. 25, no. 6, pp. 352–355, 2002. View at Scopus
  70. C. F. Gonçalves-de-Albuquerque, A. R. Silva, P. Burth et al., “Oleic acid induces lung injury in mice through activation of the ERK pathway,” Mediators of Inflammation, vol. 2012, Article ID 956509, 11 pages, 2012. View at Publisher · View at Google Scholar
  71. S. Solon, L. Lopes, P. Teixeira de Sousa Jr., and G. Schmeda-Hirschmann, “Free radical scavenging activity of Lafoensia pacari,” Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 173–178, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. V. da Mota Menezes, Á. N. Atallah, A. J. Lapa, and W. R. Catapani, “Assessing the therapeutic use of Lafoensia pacari St. Hil. extract (mangava-brava) in the eradication of Helicobacter pylori: double-blind randomized clinical trial,” Helicobacter, vol. 11, no. 3, pp. 188–195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. A. P. Rogerio, C. Fontanari, É. Borducchi et al., “Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma,” European Journal of Pharmacology, vol. 580, no. 1-2, pp. 262–270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. A. P. Rogerio, A. Sá-Nunes, D. A. Albuquerque et al., “Lafoensia pacari extract inhibits IL-5 production in toxocariasis,” Parasite Immunology, vol. 25, no. 7, pp. 393–400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. A. I. Medeiros, C. L. Silva, A. Malheiro, C. M. L. Maffei, and L. H. Faccioli, “Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the β-glucan present in their cell wall,” British Journal of Pharmacology, vol. 128, no. 7, pp. 1529–1537, 1999. View at Scopus
  76. R. Bachoual, W. Talmoudi, T. Boussetta, F. Braut, and J. El-Benna, “An aqueous pomegranate peel extract inhibits neutrophil myeloperoxidase in vitro and attenuates lung inflammation in mice,” Food and Chemical Toxicology, vol. 49, no. 6, pp. 1224–1228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Scopus
  78. R. J. Nijveldt, E. van Nood, D. E. C. van Hoorn, P. G. Boelens, K. van Norren, and P. A. M. van Leeuwen, “Flavonoids: a review of probable mechanisms of action and potential applications,” American Journal of Clinical Nutrition, vol. 74, no. 4, pp. 418–425, 2001. View at Scopus
  79. M. K. Chahar, N. Sharma, M. P. Dobhal, and Y. C. Joshi, “Flavonoids: a versatile source of anticancer drugs,” Pharmacognosy Reviews, vol. 5, no. 9, pp. 1–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. P.-G. Pietta, “Flavonoids as antioxidants,” Journal of Natural Products, vol. 63, no. 7, pp. 1035–1042, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Serafini, I. Peluso, and A. Raguzzini, “Flavonoids as anti-inflammatory agents,” Proceedings of the Nutrition Society, vol. 69, no. 3, pp. 273–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Kawai, T. Hirano, S. Higa et al., “Flavonoids and related compounds as anti-allergic substances,” Allergology International, vol. 56, no. 2, pp. 113–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Si, R. P. Wyeth, and D. Liu, “The flavonoid luteolin induces nitric oxide production and arterial relaxation,” European Journal of Nutrition, 2013. View at Publisher · View at Google Scholar
  84. Y.-C. Li, C.-H. Yeh, M.-L. Yang, and Y.-H. Kuan, “Luteolin suppresses inflammatory mediator expression by blocking the Akt/NFκB pathway in acute lung injury induced by lipopolysaccharide in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 383608, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. M.-Y. Kuo, M.-F. Liao, F.-L. Chen et al., “Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFκB pathways in mice with endotoxin-induced acute lung injury,” Food and Chemical Toxicology, vol. 49, no. 10, pp. 2660–2666, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. J.-P. Lee, Y.-C. Li, H.-Y. Chen et al., “Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils,” Acta Pharmacologica Sinica, vol. 31, no. 7, pp. 831–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. G.-L. Xu, L. Yao, S.-Q. Yu et al., “Effect of epigallocatechingallate on acute lung injury induced by oleic acid in mice,” Yao Xue Xue Bao, vol. 40, no. 3, pp. 231–235, 2005. View at Scopus
  88. H. A. Vogel and J. Pelletier, “Curcumin biological and medicinal properties,” Journal of Pharmacology, vol. 2, p. 50, 1815.
  89. Y. Henrotin, F. Priem, and A. Mobasheri, “Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management,” Springerplus, vol. 56, p. 56, 2013.
  90. G. Grynkiewicz and P. Ślifirski, “Curcumin and curcuminoids in quest for medicinal status,” Acta Biochimica Polonica, vol. 2, pp. 201–213, 2012.
  91. I. M. Leitman, “Curcumin for the prevention of acute lung injury in sepsis: is it more than the flavor of the month?” Journal of Surgical Research, vol. 176, pp. 5–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. S. C. Gupta, S. Patchva, W. Koh, and B. B. Aggarwal, “Discovery of curcumin, a component of golden spice, and its miraculous biological activities,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 3, pp. 283–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. F. Xu, S. H. Lin, Y. Z. Yang, R. Guo, J. Cao, and Q. Liu, “The effect of curcumin on sepsis-induced acute lung injury in a rat model through the inhibition of the TGF-β1/SMAD3 pathway,” International Immunopharmacology, vol. 16, pp. 1–6, 2013.
  94. X. Xiao, M. Yang, D. Sun, and S. Sun, “Curcumin protects against sepsis-induced acute lung injury in rats,” Journal of Surgical Research, vol. 1, pp. 31–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Gunaydın, A. Guzel, A. Guzel et al., “The effect of curcumin on lung injuries in a rat model induced by aspirating gastrointestinal decontamination agents,” Journal of Surgical Research, vol. 9, pp. 1669–1746, 2012.
  96. A. Guzel, M. Kanter, A. Guzel, A. F. Yucel, and M. Erboga, “Protective effect of curcumin on acute lung injury induced by intestinal ischemia/reperfusion,” Toxicology & Industrial Health, vol. 29, no. 7, pp. 633–642, 2013. View at Publisher · View at Google Scholar
  97. M. R. Smith, S. R. Gangireddy, V. R. Narala et al., “Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 298, no. 5, pp. L616–L625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Bansal and S. Chhibber, “Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice,” Journal of Medical Microbiology, vol. 59, no. 4, pp. 429–437, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. R.-F. Zhu, M. Zhou, J.-L. He, F.-Y. Ding, S.-Q. Yu, and G.-L. Xu, “Protective effect of curcumine on oleic-induced acute lung injury in rats,” Zhongguo Zhong Yao Za Zhi, vol. 33, no. 17, pp. 2141–2145, 2008. View at Scopus
  100. Q. Lian, X. Li, Y. Shang, S. Yao, L. Ma, and S. Jin, “Protective effect of curcumin on endotoxin-induced acute lung injury in rats,” Journal of Huazhong University of Science and Technology, vol. 6, pp. 678–759, 2006.
  101. P. J. Barnes, “Theophylline: new perspectives for an old drug,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 6, pp. 813–818, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. C. Guillot, M. Fornaris, M. Badier, and J. Orehek, “Spontaneous and provoked resistance to isoproterenol in isolated human bronchi,” Journal of Allergy and Clinical Immunology, vol. 74, no. 5, pp. 713–718, 1984. View at Scopus
  103. Y. Kaneko, K. Takashima, N. Suzuki, and K. Yamana, “Effects of theophylline on chronic inflammatory lung injury induced by LPS exposure in guinea pigs,” Allergology International, vol. 56, no. 4, pp. 445–456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. L. R. Fortunato, C. F. Alves, M. M. Teixeira, and A. P. Rogerio, “Quercetin: a flavonoid with the potential to treat asthma,” Brazilian Journal of Pharmaceutical Sciences, vol. 48, pp. 589–599, 2012.
  105. T. Ohrui, M. Yamaya, T. Suzuki et al., “Mechanisms of gastric juice-induced hyperpermeability of the cultured human tracheal epithelium,” Chest, vol. 111, no. 2, pp. 454–459, 1997. View at Scopus
  106. K. Hayashida, S. Fujishima, K. Sasao et al., “Early administration of sivelestat, the neutrophil elastase inhibitor, in adults for acute lung injury following gastric aspiration,” Shock, vol. 36, no. 3, pp. 223–227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. B. A. Davidson, R. R. Vethanayagam, M. J. Grimm et al., “NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury,” Journal of Immunology, vol. 190, pp. 1714–1738, 2013.
  108. H. Dang, S. Wang, L. Yang, F. Fang, and F. Xu, “Upregulation of Shh and Ptc1 in hyperoxia-induced acute lung injury in neonatal rats,” Molecular Medicine Reports, vol. 6, pp. 297–302, 2012.
  109. B. V. Patel, M. R. Wilson, and M. Takata, “Resolution of acute lung injury and inflammation: a translational mouse model,” European Respiratory Journal, vol. 39, no. 5, pp. 1162–1170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. K. Modelska, J.-F. Pittet, H. G. Folkesson, V. C. Broaddus, and M. A. Matthay, “Acid-induced lung injury: protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 5, pp. 1450–1456, 1999. View at Scopus
  111. J. W. Kuiper, F. B. Plötz, A. J. Groeneveld et al., “High tidal volume mechanical ventilation-induced lung injury in rats is greater after acid instillation than after sepsis-induced acute lung injury, but does not increase systemic inflammation: an experimental study,” BMC Anesthesiology, vol. 11, article 26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. H. Goto, J. G. Ledford, S. Mukherjee, P. W. Noble, K. L. Williams, and J. R. Wright, “The role of surfactant protein A in bleomycin-induced acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 12, pp. 1336–1344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. Y. Zhou, D. J. Schneider, E. Morschl et al., “Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury,” Journal of Immunology, vol. 186, no. 2, pp. 1097–1106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. B. B. Moore and C. M. Hogaboam, “Murine models of pulmonary fibrosis,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 294, no. 2, pp. L152–L160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Guo, F. Ji, B. Liu, X. Chen, J. He, and J. Gong, “Peiminine ameliorates bleomycin-induced acute lung injury in rats,” Molecular Medicine Reports, vol. 7, pp. 1103–1113, 2013.
  116. F. Venet, X. Huang, C.-S. Chung, Y. Chen, and A. Ayala, “Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice,” American Journal of Pathology, vol. 176, no. 2, pp. 764–773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. D. Fei, X. Meng, K. Kang et al., “Heme oxygenase-1 modulates thrombomodulin and activated protein c levels to attenuate lung injury in cecal ligation and punctureinduced acute lung injury mice,” Experimental Lung Research, vol. 38, no. 4, pp. 173–182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Xu, H. G. Bao, Y. N. Si et al., “Effects of adiponectin on acute lung injury in cecal ligation and puncture-induced sepsis rats,” Journal of Surgical Research, vol. 13, 2013.
  119. J. Villar, S. P. Ribeiro, J. B. M. Mullen, M. Kuliszewski, M. Post, and A. S. Slutsky, “Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model,” Critical Care Medicine, vol. 22, no. 6, pp. 914–921, 1994. View at Scopus
  120. Q. Pang, L. Dou, X. Pan et al., “Methylene chloride protects against cecal ligation and puncture-induced acute lung injury by modulating inflammatory mediators,” International Immunopharmacology, vol. 10, no. 8, pp. 929–932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Frank, J. R. Bucher, and R. J. Roberts, “Oxygen toxicity in neonatal and adult animals of various species,” Journal of Applied Physiology, vol. 45, no. 5, pp. 699–704, 1978. View at Scopus
  122. R. H. Kallet and M. A. Matthay, “Hyperoxic acute lung injury,” Respiratory Care, vol. 58, pp. 123–164, 2013.
  123. K. Raghavendran, J. Nemzek, L. M. Napolitano, and P. R. Knight, “Aspiration-induced lung injury,” Critical Care Medicine, vol. 39, no. 4, pp. 818–826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. R. Howden, H.-Y. Cho, L. Miller-DeGraff et al., “Cardiac physiologic and genetic predictors of hyperoxia-induced acute lung injury in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 46, no. 4, pp. 470–478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. H. D. Li, Z. R. Zhang, Q. X. Zhang, Z. C. Qin, D. M. He, and J. S. Chen, “Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice,” European Journal of Applied Physiology, vol. 113, no. 6, pp. 1555–1563, 2013. View at Publisher · View at Google Scholar
  126. J. H. Min, C. N. Codipilly, S. Nasim, E. J. Miller, and M. N. Ahmed, “Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression,” Respiratory Research, vol. 20, pp. 13–58, 2012.
  127. N. M. Reddy, S. R. Kleeberger, T. W. Kensler, M. Yamamoto, P. M. Hassoun, and S. P. Reddy, “Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice,” Journal of Immunology, vol. 182, no. 11, pp. 7264–7271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. Z. Tian, Y. Li, P. Ji, S. Zhao, and H. Cheng, “Mesenchymal stem cells protects hyperoxia-induced lung injury in newborn rats via inhibiting receptor for advanced glycation end-products/nuclear factor κB signaling,” Experimental Biology and Medicine, vol. 238, pp. 242–249, 2013.
  129. R. Fox-Dewhurst, M. K. Alberts, O. Kajikawa et al., “Pulmonary and systemic inflammatory responses in rabbits with gram- negative pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 6, pp. 2030–2040, 1997. View at Scopus
  130. A. S. Cross, S. M. Opal, J. C. Sadoff, and P. Gemski, “Choice of bacteria in animal models of sepsis,” Infection and Immunity, vol. 61, no. 7, pp. 2741–2747, 1993. View at Scopus
  131. L. R. Filgueiras Jr., J. O. Martins, C. H. Serezani, V. L. Capelozzi, M. B. Montes, and S. Jancar, “Sepsis-induced acute lung injury (ALI) is milder in diabetic rats and correlates with impaired NFkB activation,” PLoS ONE, vol. 7, no. 9, Article ID e44987, 2012. View at Publisher · View at Google Scholar
  132. R. G. Evans, O. B. Ndunge, and B. Naidu, “A novel two-hit rodent model of postoperative acute lung injury: priming the immune system leads to an exaggerated injury after pneumonectomy,” Interactive CardioVascular and Thoracic Surgery, vol. 12, 2013.
  133. Z. Guo, Q. Li, Y. Han, Y. Liang, Z. Xu, and T. Ren, “Prevention of LPS-induced acute lung injury in mice by progranulin,” Mediators of Inflammation, vol. 2012, Article ID 540794, 10 pages, 2012. View at Publisher · View at Google Scholar
  134. Y. C. Hou, M. H. Pai, J. J. Liu, and S. L. Yeh, “Alanyl-glutamine resolves lipopolysaccharide-induced lung injury in mice by modulating the polarization of regulatory T cells and T helper 17 cells,” Journal of Nutritional Biochemistry, vol. 24, no. 9, pp. 1555–1563, 2013. View at Publisher · View at Google Scholar
  135. L. Ma, X. Y. Wu, L. H. Zhang et al., “Propofol exerts anti-inflammatory effects in rats with lipopolysaccharide-induced acute lung injury by inhibition of CD14 and TLR4 expression,” Brazilian Journal of Medical and Biological Research, vol. 15, pp. 1–7, 2013.
  136. J. P. Wiener-Kronish, K. H. Albertine, and M. A. Matthay, “Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin,” The Journal of Clinical Investigation, vol. 88, no. 3, pp. 864–875, 1991. View at Scopus
  137. D.-F. Ben, X.-Y. Yu, G.-Y. Ji et al., “TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion,” Journal of Surgical Research, vol. 174, no. 2, pp. 326–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. K. Koike, F. A. Moore, E. E. Moore, R. S. Poggetti, R. M. Tuder, and A. Banerjee, “Endotoxin after gut ischemia/reperfusion causes irreversible lung injury,” Journal of Surgical Research, vol. 52, no. 6, pp. 656–662, 1992. View at Publisher · View at Google Scholar · View at Scopus
  139. A. Guzel, M. Kanter, A. Guzel, A. Pergel, and M. Erboga, “Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusion,” Journal of Molecular Histology, vol. 43, no. 3, pp. 361–369, 2012. View at Publisher · View at Google Scholar
  140. D. P. Schuster, “ARDS: clinical lessons from the oleic acid model of acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 1, pp. 245–260, 1994. View at Scopus
  141. C. Hernández-Jiménez, J. R. Olmos-Zúñiga, R. Jasso-Victoria et al., “Effects of propofol pretreatment on endothelin in oleic acid-induced acute lung injury,” Revista de Investigacion Clinica, vol. 64, pp. 452–512, 2012.
  142. Y. B. Zhu, Y. B. Zhang, D. H. Liu et al., “Atrial natriuretic peptide attenuates inflammatory responses on oleic acid-induced acute lung injury model in rats,” Chinese Medical Journal, vol. 126, pp. 747–837, 2013.
  143. D. Tok, O. Ilkgul, S. Bengmark et al., “Pretreatment with pro- and synbiotics reduces peritonitis-induced acute lung injury in rats,” Journal of Trauma, vol. 62, no. 4, pp. 880–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. C. Boland, V. Collet, E. Laterre, C. Lecuivre, X. Wittebole, and P.-F. Laterre, “Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in rats,” Inflammation, vol. 34, no. 1, pp. 29–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. D. P. Mulloy, A. K. Sharma, L. G. Fernandez et al., “Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury,” The Annals of Thoracic Surgery, vol. 28, pp. 4975–4988, 2013.
  146. T. Oyaizu, S.-Y. Fung, A. Shiozaki et al., “Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury,” Intensive Care Medicine, vol. 38, no. 5, pp. 894–905, 2012. View at Publisher · View at Google Scholar · View at Scopus
  147. H. K. Yip, Y. C. Chang, C. G. Wallace et al., “Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury,” Journal of Pineal Research, vol. 54, pp. 207–228, 2013.
  148. T. Sakuma, K. Takahashi, N. Ohya et al., “Ischemia-reperfusion lung injury in rabbits: mechanisms of injury and protection,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 276, no. 1, pp. L137–L145, 1999. View at Scopus
  149. R. D. Novaes, R. V. Gonçalves, M. C. Cupertino et al., “Bark extract of Bathysa cuspidata attenuates extra-pulmonary acute lung injury induced by paraquat and reduces mortality in rats,” International Journal of Experimental Pathology, vol. 93, pp. 225–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. C. H. Huang, M. L. Yang, C. H. Tsai, Y. C. Li, Y. J. Lin, and Y. H. Kuan, “Ginkgo biloba leaves extract (EGb 761) attenuates lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and NF-κB-dependent matrix metalloproteinase-9 pathway,” Phytomedicine, vol. 20, pp. 303–312, 2013.
  151. L. Rong, Y. Chen, M. He, and X. Zhou, “Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats,” Respirology, vol. 14, no. 6, pp. 890–898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  152. C.-Q. Yang, Y. Ishitsuka, H. Moriuchi et al., “Protection afforded by a herbal medicine, Sho-seiryu-to (TJ-19), against oleic acid-induced acute lung injury in guinea-pigs,” Journal of Pharmacy and Pharmacology, vol. 61, no. 7, pp. 925–932, 2009. View at Publisher · View at Google Scholar · View at Scopus
  153. W. Li, J. Y. Xie, H. Li et al., “Viola yedoensis liposoluble fraction ameliorates lipopolysaccharide-induced acute lung injury in mice,” American Journal of Chinese Medicine, vol. 40, no. 5, pp. 1007–1025, 2012. View at Publisher · View at Google Scholar
  154. C. R. Bezerra-Santos, A. Vieira-de-Abreu, G. C. Vieira et al., “Effectiveness of Cissampelos sympodialis and its isolated alkaloid warifteine in airway hyperreactivity and lung remodeling in a mouse model of asthma,” International Immunopharmacology, vol. 13, no. 2, pp. 148–155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  155. B. Zhang, Z.-Y. Liu, Y.-Y. Li et al., “Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice,” European Journal of Pharmaceutical Sciences, vol. 44, no. 5, pp. 573–579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. J. Mabley, S. Gordon, and P. Pacher, “Nicotine exerts an anti-inflammatory effect in a murine model of acute lung injury,” Inflammation, vol. 34, no. 4, pp. 231–237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  157. Y. F. Ni, F. Tian, Z. F. Lu et al., “Protective effect of nicotine on lipopolysaccharide-induced acute lung injury in mice,” Respiration, vol. 81, no. 1, pp. 39–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  158. L. W. Soromou, N. Chen, L. Jiang et al., “Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway,” Biochemical and Biophysical Research Communications, vol. 419, no. 2, pp. 256–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. P. Wang, X.-L. Ye, R. Liu et al., “Mechanism of acute lung injury due to phosgene exposition and its protection by cafeic acid phenethyl ester in the rat,” Experimental and Toxicologic Pathology, vol. 65, pp. 311–319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  160. Z. Wei, J. Yang, Y. F. Xia, W. Z. Huang, Z. T. Wang, and Y. Dai, “Cardamonin protects septic mice from acute lung injury by preventing endothelial barrier dysfunction,” Journal of Biochemical and Molecular Toxicology, vol. 26, pp. 282–372, 2012.
  161. X. Chen, X. Yang, T. Liu et al., “Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice,” International Immunopharmacology, vol. 14, pp. 209–225, 2012.
  162. Y. Liu, H. Wu, Y.-C. Nie, J.-L. Chen, W.-W. Su, and P.-B. Li, “Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway,” International Immunopharmacology, vol. 11, no. 10, pp. 1606–1612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  163. Y. Chen, Y. C. Nie, Y. L. Luo et al., “Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice,” Food and Chemical Toxicology, vol. 58, pp. 133–140, 2013. View at Publisher · View at Google Scholar
  164. T. L. Tseng, M. F. Chen, M. J. Tsai, Y. H. Hsu, C. P. Chen, and T. J. Lee, “Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents,” PLoS ONE, vol. 7, Article ID e47403, 2012. View at Publisher · View at Google Scholar
  165. L. Huang, J. Xianfei, and C. Cao, “Protective effects of quercetin in rats with lipopolysaccharide-induced acute lung injury,” Chinese Journal of Emergency Medicine, vol. 13, no. 2, 2004.
  166. X. Yang, Q. Cai, J. He et al., “Geniposide, an iridoid glucoside derived from gardenia jasminoides, protects against lipopolysaccharide-induced acute lung injury in mice,” Planta Medica, vol. 78, no. 6, pp. 557–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  167. X. Li, T. Xu, Q. Lian, B. Zeng, B. Zhang, and Y. Xie, “Protective effect of genistein on lipopolysaccharide-induced acute lung injury in rats,” Journal of Huazhong University of Science and Technology. Medical Sciences, vol. 25, no. 4, pp. 454–457, 2005. View at Scopus
  168. J. L. Kang, H. W. Lee, H. S. Lee, I. S. Pack, V. Castranova, and Y. Koh, “Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: relationship to alteration in nuclear factor-κB activity and inflammatory agents,” Critical Care Medicine, vol. 31, no. 2, pp. 517–524, 2003. View at Publisher · View at Google Scholar · View at Scopus
  169. M. V. Suresh, M. C. Wagner, G. R. Rosania et al., “Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury,” American Journal of Respiratory Cell and Molecular Biology, vol. 47, pp. 280–287, 2012.
  170. W. Xin, L. Zhang, H. Fan, N. Jiang, T. Wang, and F. Fu, “Escin attenuates acute lung injury induced by endotoxin in mice,” European Journal of Pharmaceutical Sciences, vol. 42, no. 1-2, pp. 73–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  171. Y.-F. Ni, J.-K. Kuai, Z.-F. Lu et al., “Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression,” Journal of Surgical Research, vol. 165, no. 1, pp. e29–e35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  172. J.-R. Shi, L.-G. Mao, R.-A. Jiang, Y. Qian, H.-F. Tang, and J.-Q. Chen, “Monoammonium glycyrrhizinate inhibited the inflammation of LPS-induced acute lung injury in mice,” International Immunopharmacology, vol. 10, no. 10, pp. 1235–1241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  173. C.-Y. Sun, C.-Q. Pei, B.-X. Zang, L. Wang, and M. Jin, “The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide- induced pulmonary inflammatory injury in mice,” Phytotherapy Research, vol. 24, no. 12, pp. 1788–1795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  174. X.-F. Wang, M. Jin, J. Tong, W. Wu, J.-R. Li, and B.-X. Zang, “Protective effect of hydroxysafflor yellow A against acute lung injury induced by oleic acid and lipopolysaccharide in rats,” Yao Xue Xue Bao, vol. 45, no. 7, pp. 940–944, 2010. View at Scopus